| Financial Year |
March 31 2023 |
| Monetary Funds |
692,520,094.10 |
| Held-for-trading Financial Assets |
702,935,585.94 |
| Notes Receivable |
-- |
| Accounts Receivable |
6,076,642.44 |
| Advances to Suppliers |
8,215,915.50 |
| Other Receivables |
1,204,951.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
32,890,792.26 |
| Other Current Assets |
125,237,102.86 |
| Total Current Assets |
1,585,263,222.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,429,940.10 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,427,007.25 |
| Under-construction Projects |
217,792.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,708,658.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,225,524.44 |
| Deferred Income Tax Assets |
50,237,008.77 |
| Other Non-Current Assets |
9,882,862.38 |
| Sub-Total of Non-Current Assets |
303,828,225.46 |
| Total Assets |
1,889,091,447.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,909,596.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,857,268.06 |
| Taxes Payable |
2,967,283.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,146,719.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
46,580,568.53 |
| Other Current Liabilities |
6,370,494.02 |
| Sub-Total of Current Liabilities |
351,963,639.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,443,232.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
180,464,155.37 |
| Total Liabilities |
532,427,794.79 |
| Paid-In Capital(Or Share Stock) |
402,447,500.00 |
| Capital Surplus |
257,361,605.82 |
| Surplus Reserve |
78,433,932.84 |
| LESS:Treasury Stock |
27,019,499.50 |
| Undistributed Profits |
645,440,113.98 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,356,663,653.14 |
| Owner's Equity（Stockholder's Equity） |
1,356,663,653.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,889,091,447.93 |
